news
Tested on plaque reducing assays, researchers have identified a lead…
8 May 2020 | By Victoria Rees (Drug Target Review)
Tested on plaque reducing assays, researchers have identified a lead candidate multivalent carbohydrate-binding module for the treatment of COVID-19.